Get startedLog in
    Picture of Enliven Therapeutics logo

    ELVN — Enliven Therapeutics News Story

    0.000.00%
    us flag iconLast trade - 00:00
    HealthcareAdventurousMid CapNeutral
    All News

    Brief: Enliven Therapeutics Reports First Quarter 2023 Financial Results

    Picture of Enliven Therapeutics logoEnliven Therapeutics
    11/05/2023 21:11
    May 11 (Reuters) - Enliven Therapeutics Inc  ELVN.O :
    * ENLIVEN THERAPEUTICS HIGHLIGHTS BUSINESS ACHIEVEMENTS AND
REPORTS FIRST QUARTER 2023 FINANCIAL RESULTS
    * ENLIVEN THERAPEUTICS INC - ENDED Q1 2023 WITH CASH & CASH
EQUIVALENTS OF ABOUT $292 MILLION, WHICH IS EXPECTED TO PROVIDE
CASH RUNWAY INTO EARLY 2026
    * ENLIVEN THERAPEUTICS INC - REPORTED NET LOSS OF $14.7
MILLION
FOR Q1 OF 2023, COMPARED TO A NET LOSS OF $8.7 MILLION FOR Q1 OF
2022

Source text for Eikon:  ID:nGNX3VX9qc 
Further company coverage:  ELVN.O 

 ((Reuters.Briefs@thomsonreuters.com;))

    Recent news on Enliven Therapeutics

    See all news